Acceso abierto

Comparative efficacy and safety of vedolizumab and antitumor necrosis factor alfa in patients with inflammatory bowel diseases: A meta‑analysis

Yafang Li

Yafang Li

Department of Gastroenterology and Hepatology, The Affiliated Jinhua Hospital Zhejiang University School of MedicineJinhua, P.R. China
Buscar este autor en
Sciendo|Google Scholar
Li, Yafang
, 
Jin Ding

Jin Ding

Department of Gastroenterology and Hepatology, The Affiliated Jinhua Hospital Zhejiang University School of MedicineJinhua, P.R. China
Perfil de Orcid
Buscar este autor en
Sciendo|Google Scholar
Ding, Jin
, 
Chong Lu

Chong Lu

Department of Gastroenterology and Hepatology, The Affiliated Jinhua Hospital Zhejiang University School of MedicineJinhua, P.R. China
Buscar este autor en
Sciendo|Google Scholar
Lu, Chong
, 
Yiping Hong

Yiping Hong

Department of Gastroenterology and Hepatology, The Affiliated Jinhua Hospital Zhejiang University School of MedicineJinhua, P.R. China
Buscar este autor en
Sciendo|Google Scholar
Hong, Yiping
 y 
Qunying Wang

Qunying Wang

Department of Gastroenterology and Hepatology, The Affiliated Jinhua Hospital Zhejiang University School of MedicineJinhua, P.R. China
Perfil de Orcid
Buscar este autor en
Sciendo|Google Scholar
Wang, Qunying
  
10 abr 2025
Comparative efficacy and safety of vedolizumab and antitumor necrosis factor alfa in patients with inflammatory bowel diseases: A meta‑analysis's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Publicado en línea: 10 abr 2025
Páginas: 23 - 40
Aceptado: 20 ene 2025
DOI: https://doi.org/10.2478/acph-2025-0004
Palabras clave
© 2025 Yafang Li et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Farmacia, Farmacia, otros
RSS Feed de revista